21:51:05 EDT Sat 27 Apr 2024
Enter Symbol
or Name
USA
CA



News for U:GENE from 2023-04-27 to 2024-04-26 - 32 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-22 15:01U:GENENews ReleaseGenetic Technologies Announces Closing of US$2 Million Registered Direct Offering
2024-04-18 12:18U:GENENews ReleaseGenetic Technologies Announces $2 Million Registered Direct Offering
2024-04-17 08:00U:GENENews ReleaseNew Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
2024-04-16 08:00U:GENENews ReleaseGeneType Clinicians' Adoption Growing - Sales up 5-Fold Year on Year
2024-04-12 09:03U:GENENews ReleaseGenetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
2024-04-11 08:00U:GENENews ReleaseGTG to pilot GeneType in Breast Screen centers across the U.S.
2024-04-08 08:00U:GENENews ReleaseEVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk"
2024-04-02 08:05U:GENENews ReleaseGenetic Technologies' Digital Strategy Ignites Significant Traction in US Market
2024-03-26 08:00U:GENENews ReleaseGTG Global Collaborations and Innovation Update
2024-03-25 08:00U:GENENews ReleaseGENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
2024-02-28 08:00U:GENENews ReleaseGTG to launch U.S. Customer Digital Media Sales Campaign
2024-01-31 08:00U:GENENews ReleaseLaunching our most comprehensive test and expanding into new global markets
2024-01-05 08:00U:GENENews ReleaseGenetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
2023-12-29 09:01U:GENENews ReleaseGenetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
2023-12-14 08:00U:GENENews ReleaseGeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
2023-12-12 08:00U:GENENews ReleaseGenetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
2023-10-30 08:00U:GENENews ReleaseGene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial
2023-10-18 08:30U:GENENews ReleaseGeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment
2023-10-06 09:03U:GENENews ReleaseKnightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
2023-09-27 09:00U:GENENews ReleaseGTG Signs Precision Medicine Pilot with Australia ¢ € ™s Largest Private Hospital Network
2023-09-15 09:02U:GENENews ReleaseAridis Pharmaceuticals, Inc., Genetic Technologies Limited, and American Resources Corporation Interviews to Air on the RedChip Money Report ‚ ® on Bloomberg TV
2023-09-12 08:00U:GENENews ReleaseBreakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian Release
2023-09-11 08:30U:GENENews ReleaseGENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry Partner
2023-09-01 10:00U:GENENews ReleaseGenetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report ‚ ® on Bloomberg TV
2023-09-01 09:01U:GENENews ReleaseGenetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
2023-08-30 08:45U:GENENews ReleaseAnnual Results ¢ € “ Momentum Building on our Commercial Plans
2023-08-09 08:00U:GENENews ReleaseGenetic Technologies Limited Announces Updated Investor Presentation
2023-07-28 08:00U:GENENews ReleaseQuarterly Activities Update: Encouraging Growth for geneType Commercial Test Volume
2023-07-21 08:00U:GENENews ReleaseGenetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
2023-05-23 08:00U:GENENews ReleaseGeneType featured on U.S. National TV to raise Breast Cancer Awareness
2023-04-28 08:00U:GENENews ReleaseNew Publication Validates geneType for Melanoma Risk Assessment
2023-04-27 08:00U:GENENews ReleaseQuarterly Business Update ¢ € “ March 2023